{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:14:08Z","timestamp":1788275648495,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Glaukos"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"DOI":"10.1007\/s12325-026-03778-y","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:42:33Z","timestamp":1788273753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Travoprost Intracameral Implant as a Standalone Procedure or Combined with Minimally Invasive Glaucoma Surgery (MIGS)"],"prefix":"10.1007","author":[{"given":"Arkadiy","family":"Yadgarov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"11","key":"3778_CR1","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/s40123-024-01041-7","volume":"13","author":"A Yadgarov","year":"2024","unstructured":"Yadgarov A, Provencher L, Shafer B, Funke C. Adopting interventional glaucoma via sustained-release therapies: the wide-ranging impact of procedural pharmaceuticals in ophthalmology. Ophthalmol Ther. 2024;13(11):2825\u201338. https:\/\/doi.org\/10.1007\/s40123-024-01041-7.","journal-title":"Ophthalmol Ther"},{"key":"3778_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9890831","volume":"2019","author":"C Posarelli","year":"2019","unstructured":"Posarelli C, Ortenzio P, Ferreras A, et al. Twenty-four-hour contact lens sensor monitoring of aqueous humor dynamics in surgically or medically treated glaucoma patients. J Ophthalmol. 2019;2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/9890831.","journal-title":"J Ophthalmol"},{"issue":"4","key":"3778_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/jop.2018.0134","volume":"35","author":"C Wolfram","year":"2019","unstructured":"Wolfram C, Stahlberg E, Pfeiffer N. Patient-reported nonadherence with glaucoma therapy. J Ocul Pharmacol Ther. 2019;35(4):223\u20138. https:\/\/doi.org\/10.1089\/jop.2018.0134.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"3778_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamaophthalmol.2018.1746","volume":"136","author":"CG De Moraes","year":"2018","unstructured":"De Moraes CG, Mansouri K, Liebmann JM, Ritch R. Association between 24-hour intraocular pressure monitored with contact lens sensor and visual field progression in older adults with glaucoma. JAMA Ophthalmol. 2018;136(7):779. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.1746.","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"3778_CR5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamaophthalmol.2022.4462","volume":"140","author":"T Nishida","year":"2022","unstructured":"Nishida T, Moghimi S, Chang AC, et al. Association of intraocular pressure with retinal nerve fiber layer thinning in patients with glaucoma. JAMA Ophthalmol. 2022;140(12):1209. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.4462.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"3778_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","volume":"127","author":"PA Newman-Casey","year":"2020","unstructured":"Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2020;127(4):477\u201383. https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.022.","journal-title":"Ophthalmology"},{"issue":"4","key":"3778_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/jop.2011.0159","volume":"29","author":"GCM Rossi","year":"2013","unstructured":"Rossi GCM, Pasinetti GM, Scudeller L, Bianchi PE. Ocular surface disease and glaucoma: how to evaluate impact on quality of life. J Ocul Pharmacol Ther. 2013;29(4):390\u20134. https:\/\/doi.org\/10.1089\/jop.2011.0159.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"3778_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","volume":"153","author":"SE Skalicky","year":"2012","unstructured":"Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153(1):1-9.e2. https:\/\/doi.org\/10.1016\/j.ajo.2011.05.033.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3778_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00061198-200106000-00017","volume":"10","author":"DC Broadway","year":"2001","unstructured":"Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma. 2001;10(3):237\u201349. https:\/\/doi.org\/10.1097\/00061198-200106000-00017.","journal-title":"J Glaucoma"},{"issue":"4","key":"3778_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","volume":"119","author":"J Landers","year":"2012","unstructured":"Landers J, Martin K, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012;119(4):694\u2013702. https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.043.","journal-title":"Ophthalmology"},{"issue":"2","key":"3778_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ophtha.2024.07.030","volume":"132","author":"SJ Gedde","year":"2025","unstructured":"Gedde SJ, Vinod K, Bowden EC, et al. Special commentary: reporting clinical endpoints in studies of minimally invasive glaucoma surgery. Ophthalmology. 2025;132(2):141\u201353. https:\/\/doi.org\/10.1016\/j.ophtha.2024.07.030.","journal-title":"Ophthalmology"},{"key":"3778_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/17469899.2025.2465330","author":"CM Funke","year":"2025","unstructured":"Funke CM, Ristvedt D, Yadgarov A, Micheletti JM. Interventional glaucoma consensus treatment protocol. Expert Rev Ophthalmol. 2025. https:\/\/doi.org\/10.1080\/17469899.2025.2465330.","journal-title":"Expert Rev Ophthalmol"},{"issue":"12","key":"3778_CR13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ophtha.2020.06.018","volume":"127","author":"FA Medeiros","year":"2020","unstructured":"Medeiros FA, Walters TR, Kolko M, et al. Phase\u00a03, randomized, 20-month study of bimatoprost implant in open-angle glaucoma and ocular hypertension (ARTEMIS 1). Ophthalmology. 2020;127(12):1627\u201341. https:\/\/doi.org\/10.1016\/j.ophtha.2020.06.018.","journal-title":"Ophthalmology"},{"issue":"17","key":"3778_CR14","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s40265-021-01624-9","volume":"81","author":"J Bacharach","year":"2021","unstructured":"Bacharach J, Tatham A, Ferguson G, et al. Phase\u00a03, randomized, 20-month study of the efficacy and safety of bimatoprost implant in patients with open-angle glaucoma and ocular hypertension (ARTEMIS 2). Drugs. 2021;81(17):2017\u201333. https:\/\/doi.org\/10.1007\/s40265-021-01624-9.","journal-title":"Drugs"},{"issue":"10","key":"3778_CR15","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s40265-024-02074-9","volume":"84","author":"IP Singh","year":"2024","unstructured":"Singh IP, Berdahl JP, Sarkisian SR, et al. Long-term safety and efficacy evaluation of travoprost intracameral implant based on pooled analyses from two phase\u00a0III trials. Drugs. 2024;84(10):1299\u2013311. https:\/\/doi.org\/10.1007\/s40265-024-02074-9.","journal-title":"Drugs"},{"issue":"4","key":"3778_CR16","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s40123-024-00898-y","volume":"13","author":"SR Sarkisian","year":"2024","unstructured":"Sarkisian SR, Ang RE, Lee AM, et al. Travoprost intracameral implant for open-angle glaucoma or ocular hypertension: 12-month results of a randomized, double-masked trial. Ophthalmol Ther. 2024;13(4):995\u20131014. https:\/\/doi.org\/10.1007\/s40123-024-00898-y.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"3778_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40265-023-01973-7","volume":"84","author":"JP Berdahl","year":"2024","unstructured":"Berdahl JP, Sarkisian SR, Ang RE, et al. Efficacy and safety of the travoprost intraocular implant in reducing topical IOP-lowering medication burden in patients with open-angle glaucoma or ocular hypertension. Drugs. 2024;84(1):83\u201397. https:\/\/doi.org\/10.1007\/s40265-023-01973-7.","journal-title":"Drugs"},{"key":"3778_CR18","doi-asserted-by":"publisher","first-page":"251584142413102","DOI":"10.1177\/25158414241310275","volume":"17","author":"IP Singh","year":"2025","unstructured":"Singh IP, Voskanyan LA, Barber KM, et al. Safety and efficacy of travoprost intracameral implant administered in combination with cataract surgery. Ther Adv Ophthalmol. 2025;17:25158414241310276. https:\/\/doi.org\/10.1177\/25158414241310275.","journal-title":"Ther Adv Ophthalmol"},{"key":"3778_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/OPTH.S498431","volume":"19","author":"S Teymoorian","year":"2025","unstructured":"Teymoorian S, Kaur J. Travoprost intracameral implant in eyes with glaucoma or ocular hypertension: early short-term real-world outcomes. Clin Ophthalmol. 2025;19:157\u201366. https:\/\/doi.org\/10.2147\/OPTH.S498431.","journal-title":"Clin Ophthalmol"},{"key":"3778_CR20","doi-asserted-by":"publisher","unstructured":"AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol. 2001;132(3):311\u201320. https:\/\/doi.org\/10.1016\/s0002-9394(01)01028-5","DOI":"10.1016\/s0002-9394(01)01028-5"},{"issue":"11","key":"3778_CR21","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/s0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943\u201353. https:\/\/doi.org\/10.1016\/s0161-6420(01)00873-9.","journal-title":"Ophthalmology"},{"issue":"2","key":"3778_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/J.OPHTHA.2022.09.009","volume":"130","author":"G Gazzard","year":"2023","unstructured":"Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Laser in glaucoma and ocular hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology. 2023;130(2):139\u201351. https:\/\/doi.org\/10.1016\/J.OPHTHA.2022.09.009.","journal-title":"Ophthalmology"},{"issue":"1","key":"3778_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40123-024-01073-z","volume":"14","author":"JM Micheletti","year":"2025","unstructured":"Micheletti JM, Shultz M, Singh IP, Samuelson TW. An emerging multi-mechanism and multi-modal approach in interventional glaucoma therapy. Ophthalmol Ther. 2025;14(1):13\u201322. https:\/\/doi.org\/10.1007\/s40123-024-01073-z.","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"3778_CR24","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jcrs.2014.07.004","volume":"40","author":"IIK Ahmed","year":"2014","unstructured":"Ahmed IIK, Katz LJ, Chang DF, et al. Prospective evaluation of microinvasive glaucoma surgery with trabecular microbypass stents and prostaglandin in open-angle glaucoma. J Cataract Refract Surg. 2014;40(8):1295\u2013300. https:\/\/doi.org\/10.1016\/j.jcrs.2014.07.004.","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"3778_CR25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/ceo.13763","volume":"48","author":"J Berdahl","year":"2020","unstructured":"Berdahl J, Voskanyan L, Myers JS, Katz LJ, Samuelson TW. iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes. Clin Exp Ophthalmol. 2020;48(6):767\u201374. https:\/\/doi.org\/10.1111\/ceo.13763.","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"3778_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12325-018-0666-4","volume":"35","author":"JS Myers","year":"2018","unstructured":"Myers JS, Masood I, Hornbeak DM, et al. Prospective evaluation of two iStent\u00ae trabecular stents, one iStent Supra\u00ae suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes. Adv Ther. 2018;35(3):395\u2013407. https:\/\/doi.org\/10.1007\/s12325-018-0666-4.","journal-title":"Adv Ther"},{"issue":"3","key":"3778_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jcrs.2016.12.020","volume":"43","author":"TJ Ferguson","year":"2017","unstructured":"Ferguson TJ, Swan R, Sudhagoni R, Berdahl JP. Microbypass stent implantation with cataract extraction and endocyclophotocoagulation versus microbypass stent with cataract extraction for glaucoma. J Cataract Refract Surg. 2017;43(3):377\u201382. https:\/\/doi.org\/10.1016\/j.jcrs.2016.12.020.","journal-title":"J Cataract Refract Surg"},{"key":"3778_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/OPTH.S504247","volume":"19","author":"MS Porter","year":"2025","unstructured":"Porter MS, Flowers A, Wood BP, Gallardo MJ. Efficacy and safety of cataract surgery combined with ab interno canaloplasty and micro-trabecular bypass stent surgery in open-angle glaucoma. Clin Ophthalmol. 2025;19:469\u201381. https:\/\/doi.org\/10.2147\/OPTH.S504247.","journal-title":"Clin Ophthalmol"},{"key":"3778_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OPTH.S597257","volume":"20","author":"A Yadgarov","year":"2026","unstructured":"Yadgarov A. Early real-world safety and short-term outcomes of combined iStent infinite and intracameral travoprost implant (iDose TR) with or without cataract surgery. Clin Ophthalmol. 2026;20:1\u201311. https:\/\/doi.org\/10.2147\/OPTH.S597257.","journal-title":"Clin Ophthalmol"},{"key":"3778_CR30","volume-title":"Clinical decisions in glaucoma","author":"E Hodapp","year":"1993","unstructured":"Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St Louis (MO): Mosby; 1993."},{"issue":"6","key":"3778_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/08820538.2023.2181665","volume":"38","author":"DD Mai","year":"2023","unstructured":"Mai DD, Ingram Z, Oberfeld B, Sol\u00e1-Del Valle D. Combined microinvasive glaucoma surgery\u2014a review of the literature and future directions. Semin Ophthalmol. 2023;38(6):529\u201336. https:\/\/doi.org\/10.1080\/08820538.2023.2181665.","journal-title":"Semin Ophthalmol"},{"key":"3778_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OPTH.S576540","volume":"20","author":"J Spaulding","year":"2026","unstructured":"Spaulding J. Effectiveness and safety of combined ab-interno canaloplasty and microstent implantation in severe glaucoma\u2014a retrospective study. Clin Ophthalmol. 2026;20:1\u201310. https:\/\/doi.org\/10.2147\/OPTH.S576540.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"3778_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/aos.13790","volume":"96","author":"C Lind\u00e9n","year":"2018","unstructured":"Lind\u00e9n C, Heijl A, J\u00f3hannesson G, Aspberg J, Andersson Geimer S, Bengtsson B. Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study. Acta Ophthalmol. 2018;96(6):567\u201372. https:\/\/doi.org\/10.1111\/aos.13790.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"3778_CR34","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/IJG.0000000000002261","volume":"32","author":"K Acuff","year":"2023","unstructured":"Acuff K, Radha Saseendrakumar B, Wu JH, Weinreb RN, Baxter SL. Racial, ethnic, and socioeconomic disparities in glaucoma onset and severity in a diverse nationwide cohort in the United States. J Glaucoma. 2023;32(9):792\u20139. https:\/\/doi.org\/10.1097\/IJG.0000000000002261.","journal-title":"J Glaucoma"},{"issue":"1","key":"3778_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/08820538.2022.2152702","volume":"38","author":"AM Wu","year":"2023","unstructured":"Wu AM, Shen LQ. Racial disparities affecting Black patients in glaucoma diagnosis and management. Semin Ophthalmol. 2023;38(1):65\u201375. https:\/\/doi.org\/10.1080\/08820538.2022.2152702.","journal-title":"Semin Ophthalmol"},{"key":"3778_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OPTH.S564425","volume":"20","author":"K Gillmann","year":"2014","unstructured":"Gillmann K, Baudouin C, Masood I, et al. A systematic and narrative review of safety and complications in minimally invasive glaucoma surgery (MIGS) between 2014\u20132024. Clin Ophthalmol (Auckl). 2014;20:1\u201330. https:\/\/doi.org\/10.2147\/OPTH.S564425.","journal-title":"Clin Ophthalmol (Auckl)"},{"issue":"12","key":"3778_CR37","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.jcrs.2016.10.013","volume":"42","author":"S Manning","year":"2016","unstructured":"Manning S, Barry P, Henry Y, et al. Femtosecond laser\u2013assisted cataract surgery versus standard phacoemulsification cataract surgery: study from the European Registry of Quality Outcomes for Cataract and Refractive Surgery. J Cataract Refract Surg. 2016;42(12):1779\u201390. https:\/\/doi.org\/10.1016\/j.jcrs.2016.10.013.","journal-title":"J Cataract Refract Surg"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03778-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:42:34Z","timestamp":1788273754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03778-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":37,"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03778-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Arkadiy Yadgarov is a consultant to Glaukos Corporation.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study abided by the Declaration of Helsinki and Health Insurance Portability and Accountability Act (HIPAA) privacy standards. Written informed patient consent was obtained for the surgical procedure(s). All data were de-identified using unique case\u00a0IDs. Informed consent for the study was waived by Salus IRB (Austin, Texas, USA; Salus Number 26010) as this was a retrospective analysis of data collected during routine clinical care. The study was determined to be exempt from institutional review board oversight by Salus IRB as per 45 CFR 46.104(d)(4), and waiver of HIPAA authorization was approved under 45 CFR 164.512(i)(2).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}